Investigational Drug Information for dapansutrile
✉ Email this page to a colleague
What is the development status for investigational drug dapansutrile?
dapansutrile is an investigational drug.
There have been 6 clinical trials for dapansutrile.
The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2022.
The most common disease conditions in clinical trials are Syndrome, Gout, and Arthritis, Gouty. The leading clinical trial sponsors are Olatec Therapeutics LLC, Merck Sharp & Dohme Corp., and April Salama, M.D.
Summary for dapansutrile
| US Patents | 0 |
| International Patents | 26 |
| US Patent Applications | 41 |
| WIPO Patent Applications | 22 |
| Japanese Patent Applications | 7 |
| Clinical Trial Progress | Phase 1 (2022-12-01) |
| Vendors | 38 |
Recent Clinical Trials for dapansutrile
| Title | Sponsor | Phase |
|---|---|---|
| Advanced Cardiovascular Imaging of the Systemic Effects of Inflammasome Activation | University of Virginia | Early Phase 1 |
| Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare | Olatec Therapeutics LLC | Phase 2/Phase 3 |
| A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma | Merck Sharp & Dohme Corp. | Phase 1/Phase 2 |
Clinical Trial Summary for dapansutrile
Top disease conditions for dapansutrile
Top clinical trial sponsors for dapansutrile
US Patents for dapansutrile
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for dapansutrile
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Dapansutrile | Australia | AU2011344030 | 2030-12-15 | ⤷ Try a Trial |
| Dapansutrile | Brazil | BR112013014583 | 2030-12-15 | ⤷ Try a Trial |
| Dapansutrile | Canada | CA2820625 | 2030-12-15 | ⤷ Try a Trial |
| Dapansutrile | China | CN103260613 | 2030-12-15 | ⤷ Try a Trial |
| Dapansutrile | European Patent Office | EP2651407 | 2030-12-15 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
